Pfizer Inc. Proxy Statement Reminder Filed
Ticker: PFE · Form: DEFA14A · Filed: Apr 9, 2024 · CIK: 78003
| Field | Detail |
|---|---|
| Company | Pfizer Inc (PFE) |
| Form Type | DEFA14A |
| Filed Date | Apr 9, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, shareholder-meeting, voting
Related Tickers: PFE
TL;DR
Pfizer filed proxy materials, get ready to vote!
AI Summary
Pfizer Inc. filed a Definitive Additional Materials proxy statement (DEFA14A) on April 9, 2024. This filing serves as a reminder to shareholders regarding upcoming voting matters. The document is related to the company's annual meeting and the solicitation of proxies for shareholder votes.
Why It Matters
This filing is a procedural step to ensure shareholders are informed and can participate in corporate governance decisions at Pfizer's upcoming annual meeting.
Risk Assessment
Risk Level: low — This is a standard procedural filing for a large public company and does not contain new material financial information or strategic changes.
Key Players & Entities
- PFIZER INC (company) — Registrant
- 0000078003-24-000094 (filing_id) — Accession Number
- 20240409 (date) — Filing Date
FAQ
What type of filing is this DEFA14A for Pfizer Inc.?
This filing is a Definitive Additional Materials proxy statement, serving as a vote reminder.
When was this filing submitted to the SEC?
The filing was submitted on April 9, 2024.
What is the purpose of a DEFA14A filing?
A DEFA14A filing is used for proxy statements, which solicit shareholder votes on corporate matters.
Who is the filer of this document?
The filer is Pfizer Inc., the Registrant.
What is Pfizer Inc.'s Central Index Key (CIK)?
Pfizer Inc.'s CIK is 0000078003.
Filing Stats: 131 words · 1 min read · ~1 pages · Grade level 14.1 · Accepted 2024-04-09 10:29:32
Filing Documents
- votereminder24_defax14a.htm (DEFA14A) — 10KB
- reminder24v001.jpg (GRAPHIC) — 161KB
- 0000078003-24-000094.txt ( ) — 232KB
From the Filing
VOTE REMINDER Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party Other Than the Registrant Check the Appropriate Box Preliminary Proxy Statement Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement x Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 Pfizer Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of filing fee (Check all boxes that apply) x No fee required Fee paid previously with preliminary materials Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11